Baxter International BAX Net Revenue Royalties — Maximum contingent future payments
Discontinued — last reported Q1 '18
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh.
The official record: Baxter International’s 10-K, filed February 11, 2021, on SEC EDGAR. View the filing →
Questions, answered.
- What does net revenue royalties — maximum contingent future payments mean?
- The maximum amount of money the company might have to pay to partners based on future sales milestones.
- How do you interpret net revenue royalties — maximum contingent future payments?
- An increase suggests higher potential future obligations tied to successful product performance, while a decrease indicates a reduction in contingent liabilities or the expiration of milestone periods.
- How does net revenue royalties — maximum contingent future payments compare across companies?
- Comparable to contingent consideration or milestone payment obligations reported by other medical device and pharmaceutical companies that rely on in-licensed technology.